Electromagnetic treatment to old Alzheimer's mice reverses β-amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit.

Few studies have investigated physiologic and cognitive effects of "long-term" electromagnetic field (EMF) exposure in humans or animals. Our recent studies have provided initial insight into the long-term impact of adulthood EMF exposure (GSM, pulsed/modulated, 918 MHz, 0.25-1.05 W/kg) by...

Full description

Bibliographic Details
Main Authors: Gary W Arendash, Takashi Mori, Maggie Dorsey, Rich Gonzalez, Naoki Tajiri, Cesar Borlongan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3338462?pdf=render
_version_ 1818381803161911296
author Gary W Arendash
Takashi Mori
Maggie Dorsey
Rich Gonzalez
Naoki Tajiri
Cesar Borlongan
author_facet Gary W Arendash
Takashi Mori
Maggie Dorsey
Rich Gonzalez
Naoki Tajiri
Cesar Borlongan
author_sort Gary W Arendash
collection DOAJ
description Few studies have investigated physiologic and cognitive effects of "long-term" electromagnetic field (EMF) exposure in humans or animals. Our recent studies have provided initial insight into the long-term impact of adulthood EMF exposure (GSM, pulsed/modulated, 918 MHz, 0.25-1.05 W/kg) by showing 6+ months of daily EMF treatment protects against or reverses cognitive impairment in Alzheimer's transgenic (Tg) mice, while even having cognitive benefit to normal mice. Mechanistically, EMF-induced cognitive benefits involve suppression of brain β-amyloid (Aβ) aggregation/deposition in Tg mice and brain mitochondrial enhancement in both Tg and normal mice. The present study extends this work by showing that daily EMF treatment given to very old (21-27 month) Tg mice over a 2-month period reverses their very advanced brain Aβ aggregation/deposition. These very old Tg mice and their normal littermates together showed an increase in general memory function in the Y-maze task, although not in more complex tasks. Measurement of both body and brain temperature at intervals during the 2-month EMF treatment, as well as in a separate group of Tg mice during a 12-day treatment period, revealed no appreciable increases in brain temperature (and no/slight increases in body temperature) during EMF "ON" periods. Thus, the neuropathologic/cognitive benefits of EMF treatment occur without brain hyperthermia. Finally, regional cerebral blood flow in cerebral cortex was determined to be reduced in both Tg and normal mice after 2 months of EMF treatment, most probably through cerebrovascular constriction induced by freed/disaggregated Aβ (Tg mice) and slight body hyperthermia during "ON" periods. These results demonstrate that long-term EMF treatment can provide general cognitive benefit to very old Alzheimer's Tg mice and normal mice, as well as reversal of advanced Aβ neuropathology in Tg mice without brain heating. Results further underscore the potential for EMF treatment against AD.
first_indexed 2024-12-14T02:40:23Z
format Article
id doaj.art-2d20de50fc93457093b27fcd310bd8fe
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T02:40:23Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-2d20de50fc93457093b27fcd310bd8fe2022-12-21T23:20:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0174e3575110.1371/journal.pone.0035751Electromagnetic treatment to old Alzheimer's mice reverses β-amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit.Gary W ArendashTakashi MoriMaggie DorseyRich GonzalezNaoki TajiriCesar BorlonganFew studies have investigated physiologic and cognitive effects of "long-term" electromagnetic field (EMF) exposure in humans or animals. Our recent studies have provided initial insight into the long-term impact of adulthood EMF exposure (GSM, pulsed/modulated, 918 MHz, 0.25-1.05 W/kg) by showing 6+ months of daily EMF treatment protects against or reverses cognitive impairment in Alzheimer's transgenic (Tg) mice, while even having cognitive benefit to normal mice. Mechanistically, EMF-induced cognitive benefits involve suppression of brain β-amyloid (Aβ) aggregation/deposition in Tg mice and brain mitochondrial enhancement in both Tg and normal mice. The present study extends this work by showing that daily EMF treatment given to very old (21-27 month) Tg mice over a 2-month period reverses their very advanced brain Aβ aggregation/deposition. These very old Tg mice and their normal littermates together showed an increase in general memory function in the Y-maze task, although not in more complex tasks. Measurement of both body and brain temperature at intervals during the 2-month EMF treatment, as well as in a separate group of Tg mice during a 12-day treatment period, revealed no appreciable increases in brain temperature (and no/slight increases in body temperature) during EMF "ON" periods. Thus, the neuropathologic/cognitive benefits of EMF treatment occur without brain hyperthermia. Finally, regional cerebral blood flow in cerebral cortex was determined to be reduced in both Tg and normal mice after 2 months of EMF treatment, most probably through cerebrovascular constriction induced by freed/disaggregated Aβ (Tg mice) and slight body hyperthermia during "ON" periods. These results demonstrate that long-term EMF treatment can provide general cognitive benefit to very old Alzheimer's Tg mice and normal mice, as well as reversal of advanced Aβ neuropathology in Tg mice without brain heating. Results further underscore the potential for EMF treatment against AD.http://europepmc.org/articles/PMC3338462?pdf=render
spellingShingle Gary W Arendash
Takashi Mori
Maggie Dorsey
Rich Gonzalez
Naoki Tajiri
Cesar Borlongan
Electromagnetic treatment to old Alzheimer's mice reverses β-amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit.
PLoS ONE
title Electromagnetic treatment to old Alzheimer's mice reverses β-amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit.
title_full Electromagnetic treatment to old Alzheimer's mice reverses β-amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit.
title_fullStr Electromagnetic treatment to old Alzheimer's mice reverses β-amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit.
title_full_unstemmed Electromagnetic treatment to old Alzheimer's mice reverses β-amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit.
title_short Electromagnetic treatment to old Alzheimer's mice reverses β-amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit.
title_sort electromagnetic treatment to old alzheimer s mice reverses β amyloid deposition modifies cerebral blood flow and provides selected cognitive benefit
url http://europepmc.org/articles/PMC3338462?pdf=render
work_keys_str_mv AT garywarendash electromagnetictreatmenttooldalzheimersmicereversesbamyloiddepositionmodifiescerebralbloodflowandprovidesselectedcognitivebenefit
AT takashimori electromagnetictreatmenttooldalzheimersmicereversesbamyloiddepositionmodifiescerebralbloodflowandprovidesselectedcognitivebenefit
AT maggiedorsey electromagnetictreatmenttooldalzheimersmicereversesbamyloiddepositionmodifiescerebralbloodflowandprovidesselectedcognitivebenefit
AT richgonzalez electromagnetictreatmenttooldalzheimersmicereversesbamyloiddepositionmodifiescerebralbloodflowandprovidesselectedcognitivebenefit
AT naokitajiri electromagnetictreatmenttooldalzheimersmicereversesbamyloiddepositionmodifiescerebralbloodflowandprovidesselectedcognitivebenefit
AT cesarborlongan electromagnetictreatmenttooldalzheimersmicereversesbamyloiddepositionmodifiescerebralbloodflowandprovidesselectedcognitivebenefit